Company Filing History:
Years Active: 2014-2023
Title: Francesca Magnani: Innovator in G-Protein Coupled Receptors
Introduction
Francesca Magnani is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the study of G-protein coupled receptors (GPCRs). With a total of 3 patents to her name, her work has advanced the understanding and application of these crucial proteins.
Latest Patents
Francesca's latest patents include innovative methods and compositions related to mutant G-protein coupled receptors. One of her notable inventions is focused on mutant G-protein coupled receptors with increased conformational stability. This invention provides polynucleotides encoding these mutant receptors and host cells that comprise them. Additionally, she has developed methods for screening binding partners of GPCRs, which involve producing conformational specific binding partners and isolating test compounds that bind to the mutant GPCRs. These advancements have the potential to enhance drug discovery and therapeutic applications.
Career Highlights
Francesca Magnani has established herself as a key figure in her field through her work at Heptares Therapeutics Limited. Her research has not only contributed to the scientific community but has also paved the way for new therapeutic strategies targeting GPCRs. Her innovative approaches have garnered attention and respect within the industry.
Collaborations
Francesca has collaborated with esteemed colleagues, including Richard Henderson and Christopher Gordon Tate. These partnerships have further enriched her research and have led to significant advancements in the understanding of GPCRs.
Conclusion
Francesca Magnani's contributions to the field of biochemistry, particularly in the area of G-protein coupled receptors, highlight her role as an influential inventor. Her innovative patents and collaborative efforts continue to shape the future of therapeutic development.